de Hoop Esther, van der Tweel Ingeborg, van der Graaf Rieke, Moons Karel G M, van Delden Johannes J M, Reitsma Johannes B, Koffijberg Hendrik
Department of Biostatistics and Research Support, University Medical Center Utrecht, Julius Center for Health Sciences and Primary Care, PO Box 85500, Utrecht, 3508, GA, The Netherlands.
Department of Medical Humanities, University Medical Center Utrecht, Julius Center for Health Sciences and Primary Care, PO Box 85500, Utrecht, 3508, GA, The Netherlands.
BMC Med Res Methodol. 2015 Oct 30;15:93. doi: 10.1186/s12874-015-0090-2.
Various papers have addressed pros and cons of the stepped wedge cluster randomized trial design (SWD). However, some issues have not or only limitedly been addressed. Our aim was to provide a comprehensive overview of all merits and limitations of the SWD to assist researchers, reviewers and medical ethics committees when deciding on the appropriateness of the SWD for a particular study.
We performed an initial search to identify articles with a methodological focus on the SWD, and categorized and discussed all reported advantages and disadvantages of the SWD. Additional aspects were identified during multidisciplinary meetings in which ethicists, biostatisticians, clinical epidemiologists and health economists participated. All aspects of the SWD were compared to the parallel group cluster randomized design. We categorized the merits and limitations of the SWD to distinct phases in the design and conduct of such studies, highlighting that their impact may vary depending on the context of the study or that benefits may be offset by drawbacks across study phases. Furthermore, a real-life illustration is provided.
New aspects are identified within all disciplines. Examples of newly identified aspects of an SWD are: the possibility to measure a treatment effect in each cluster to examine the (in)consistency in effects across clusters, the detrimental effect of lower than expected inclusion rates, deviation from the ordinary informed consent process and the question whether studies using the SWD are likely to have sufficient social value. Discussions are provided on e.g. clinical equipoise, social value, health economical decision making, number of study arms, and interim analyses.
Deciding on the use of the SWD involves aspects and considerations from different disciplines not all of which have been discussed before. Pros and cons of this design should be balanced in comparison to other feasible design options as to choose the optimal design for a particular intervention study.
多篇论文探讨了阶梯楔形整群随机试验设计(SWD)的优缺点。然而,一些问题尚未得到充分探讨或仅得到有限的关注。我们的目的是全面概述SWD的所有优点和局限性,以帮助研究人员、审稿人和医学伦理委员会确定SWD在特定研究中的适用性。
我们进行了初步检索,以识别侧重于SWD方法学的文章,并对所有已报道的SWD优缺点进行分类和讨论。在伦理学家、生物统计学家、临床流行病学家和卫生经济学家参与的多学科会议上,还确定了其他方面。将SWD的所有方面与平行组整群随机设计进行比较。我们将SWD的优缺点分类到此类研究设计和实施的不同阶段,强调其影响可能因研究背景而异,或者在研究的不同阶段,优点可能会被缺点抵消。此外,还提供了一个实际案例。
在所有学科中都发现了新的方面。SWD新发现的方面包括:在每个整群中测量治疗效果以检验各整群间效果的(不)一致性的可能性、纳入率低于预期的不利影响、偏离常规知情同意程序以及使用SWD的研究是否可能具有足够社会价值的问题。还对例如临床 equipoise、社会价值、卫生经济决策、研究组数量和中期分析等进行了讨论。
决定是否使用SWD涉及不同学科的多个方面和考量,其中并非所有方面此前都有过讨论。与其他可行的设计选项相比,应权衡这种设计的优缺点,以便为特定的干预研究选择最佳设计。